Proton Pump Inhibitor Use and Enteric Infections : Clinical Implications of Chronic Therapy for GERDSANDRA DIAL, M.The American journal of gastroenterology. 2009, Vol 104, Num 2, issn 0002-9270, S10-S16 [7 p.], SUPArticle

The proton-pump inhibitor test: pros and consBRULEY DES VARANNES, Stanislas.European journal of gastroenterology & hepatology. 2004, Vol 16, Num 9, pp 847-852, issn 0954-691X, 6 p.Article

Management of heartburn not responding to proton pump inhibitorsFASS, R; SIFRIM, D.Gut. 2009, Vol 58, Num 2, pp 295-309, issn 0017-5749, 15 p.Article

Proton pump inhibitors and gastric neoplasiaKUIPERS, E. J.Gut. 2006, Vol 55, Num 9, pp 1217-1221, issn 0017-5749, 5 p.Article

CYP2C19 polymorphism and Proton pump inhibitorsKLOTZ, Ulrich; SCHWAB, Matthias; TREIBER, Gerhard et al.Basic & clinical pharmacology & toxicology (Print). 2004, Vol 95, Num 1, pp 2-8, issn 1742-7835, 7 p.Article

Proton pump inhibitors: actions and reactionsMULLIN, James M; GABELLO, Melissa; MURRAY, Lisa J et al.Drug discovery today. 2009, Vol 14, Num 13-14, pp 647-660, issn 1359-6446, 14 p.Article

Extraesophageal symptoms: What role for the proton pump inhibitors?NORD, H. Juergen.The American journal of medicine. 2004, Vol 117, pp 56S-62S, issn 0002-9343, SUP5AConference Paper

The long-term use of proton-pump inhibitorsRAGHUNATH, A. S; O'MORAIN, C; MCLOUGHLIN, R. C et al.Alimentary pharmacology & therapeutics. Supplement. 2005, Vol 22, Num 1, pp 55-63, issn 0953-0673, 9 p.Article

Drug-Drug Interaction Profiles of Proton Pump InhibitorsOGAWA, Ryuichi; ECHIZEN, Hirotoshi.Clinical pharmacokinetics. 2010, Vol 49, Num 8, pp 509-533, issn 0312-5963, 25 p.Article

Effect of Proton Pump Inhibitors on Vitamins and Iron : Clinical Implications of Chronic Therapy for GERDMCCOLL, Kenneth E. L.The American journal of gastroenterology. 2009, Vol 104, Num 2, issn 0002-9270, S5-S9 [5 p.], SUPArticle

The Safety of Proton Pump Inhibitors (PPIs) in Pregnancy: A Meta-AnalysisGILL, Simerpal K; O'BRIEN, Lisa; EINARSON, Thomas R et al.The American journal of gastroenterology. 2009, Vol 104, Num 6, pp 1541-1545, issn 0002-9270, 5 p.Article

Proton Pump Inhibitor Failure-What Are the Therapeutic Options?FASS, Ronnie.The American journal of gastroenterology. 2009, Vol 104, Num 2, issn 0002-9270, S33-S39 [6 p.], SUPArticle

The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H₂ antagonist therapyHIROTA, Kazuyoshi; KUDO, Mihoko; HASHIMOTO, Hiroshi et al.Anesthesia and analgesia. 2005, Vol 101, Num 4, pp 1038-1041, issn 0003-2999, 4 p.Article

Proton Pump Inhibitors: The Good, the Bad, and the UnwantedCHUBINEH, Saman; BIRK, John.Southern medical journal (Birmingham, Ala. Print). 2012, Vol 105, Num 11, pp 613-618, issn 0038-4348, 6 p.Article

A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trialBOECKXSTAENS, Guy E; BEAUMONT, Hanneke; HATLEBAKK, Jan G et al.Gut. 2011, Vol 60, Num 9, pp 1182-1188, issn 0017-5749, 7 p.Article

BMI is superior to symptoms in predicting response to proton pump inhibitor: randomised trial in patients with upper gastrointestinal symptoms and normal endoscopyFLETCHER, Jonathan; DERAKHSHAN, Mohammad H; JONES, Gareth-Rhys et al.Gut. 2011, Vol 60, Num 4, pp 442-448, issn 0017-5749, 7 p.Article

Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the NetherlandsVAN BOXEL, O. S; HAGENAARS, M. P; SMOUT, A. J. P. M et al.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 5, pp 571-579, issn 0269-2813, 9 p.Article

Inappropriate prescribing of proton pump inhibitors in primary careBATUWITAGE, Bisanth Thushila; KINGHAM, Jeremy G. C; MORGAN, Nia Emma et al.Postgraduate medical journal. 2007, Vol 83, Num 975, pp 66-68, issn 0032-5473, 3 p.Article

Association Between Recent Use of Proton Pump Inhibitors and Nontyphoid Salmonellosis: A Nested Case-Control StudyWU, Hau-Hsin; CHEN, Yung-Tai; SHIH, Chia-Jen et al.Clinical infectious diseases. 2014, Vol 59, Num 11, pp 1554-1558, issn 1058-4838, 5 p.Article

Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?HEIDELBAUGH, J. J; METZ, D. C; YANG, Y.-X et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 6, pp 582-591, issn 1368-5031, 10 p.Article

Sécurité des inhibiteurs de pompes à protons (IPP) = Safety of PPIsBRETAGNE, Jean-François.Hépato-gastro (Montrouge). 2011, Vol 18, Num 5, pp 519-527, issn 1253-7020, 9 p.Conference Paper

Persistence and adherence to proton pump inhibitors in daily clinical practiceVAN SOEST, E. M; SIERSEMA, P. D; DIELEMAN, J. P et al.Alimentary pharmacology & therapeutics. 2006, Vol 24, Num 2, pp 377-385, issn 0269-2813, 9 p.Article

Review article : the clinical pharmacology of proton pump inhibitorsSACHS, G; SHIN, J. M; HOWDEN, C. W et al.Alimentary pharmacology & therapeutics. Supplement. 2006, Vol 23, Num 2, pp 2-8, issn 0953-0673, 7 p.Conference Paper

Therapeutic choices in reflux disease: Defining the criteria for selecting a proton pump inhibitorFRESTON, James W.The American journal of medicine. 2004, Vol 117, pp 14S-22S, issn 0002-9343, SUP5AConference Paper

Gastric carcinoids after long-term use of a proton pump inhibitorJIANU, C. S; FOSSMARK, R; VISET, T et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 7, pp 644-649, issn 0269-2813, 6 p.Article